152 related articles for article (PubMed ID: 19327324)
21. Addition of vasopressin to norepinephrine as independent predictor of mortality in patients with refractory septic shock: an observational study.
Micek ST; Shah P; Hollands JM; Shah RA; Shannon WD; Kollef MH
Surg Infect (Larchmt); 2007 Apr; 8(2):189-200. PubMed ID: 17437364
[TBL] [Abstract][Full Text] [Related]
22. Comparison of systemic and renal effects of dopexamine and dopamine in norepinephrine-treated septic shock.
Schmoelz M; Schelling G; Dunker M; Irlbeck M
J Cardiothorac Vasc Anesth; 2006 Apr; 20(2):173-8. PubMed ID: 16616656
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of dopamine versus norepinephrine in the management of septic shock.
Patel GP; Grahe JS; Sperry M; Singla S; Elpern E; Lateef O; Balk RA
Shock; 2010 Apr; 33(4):375-80. PubMed ID: 19851126
[TBL] [Abstract][Full Text] [Related]
24. The outcome of patients with sepsis and septic shock presenting to emergency departments in Australia and New Zealand.
;
Crit Care Resusc; 2007 Mar; 9(1):8-18. PubMed ID: 17352661
[TBL] [Abstract][Full Text] [Related]
25. Fluconazole improves survival in septic shock: a randomized double-blind prospective study.
Jacobs S; Price Evans DA; Tariq M; Al Omar NF
Crit Care Med; 2003 Jul; 31(7):1938-46. PubMed ID: 12847386
[TBL] [Abstract][Full Text] [Related]
26. Effect of dopamine and metaraminol on the renal function of patients with septic shock.
Hou LC; Li SZ; Xiong LZ; Chen SY; Chen M; Zhang XJ; Huo TT; Wang Q; Wang YL; Hu WN
Chin Med J (Engl); 2007 Apr; 120(8):680-3. PubMed ID: 17517184
[TBL] [Abstract][Full Text] [Related]
27. Survival analysis of 314 episodes of sepsis in medical intensive care unit in university hospital: impact of intensive care unit performance and antimicrobial therapy.
Degoricija V; Sharma M; Legac A; Gradiser M; Sefer S; Vucicević Z
Croat Med J; 2006 Jun; 47(3):385-97. PubMed ID: 16758516
[TBL] [Abstract][Full Text] [Related]
28. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock.
Mehta NJ; Khan IA; Gupta V; Jani K; Gowda RM; Smith PR
Int J Cardiol; 2004 May; 95(1):13-7. PubMed ID: 15159032
[TBL] [Abstract][Full Text] [Related]
29. The effect of time to antifungal therapy on mortality in Candidemia associated septic shock.
Patel GP; Simon D; Scheetz M; Crank CW; Lodise T; Patel N
Am J Ther; 2009; 16(6):508-11. PubMed ID: 19531934
[TBL] [Abstract][Full Text] [Related]
30. Vasopressor use in septic shock: an update.
Leone M; Martin C
Curr Opin Anaesthesiol; 2008 Apr; 21(2):141-7. PubMed ID: 18443479
[TBL] [Abstract][Full Text] [Related]
31. Comparing hydrocortisone and methylprednisolone in patients with septic shock.
Yu TJ; Liu YC; Yu CC; Tseng JC; Hua CC; Wu HP
Adv Ther; 2009 Jul; 26(7):728-35. PubMed ID: 19629409
[TBL] [Abstract][Full Text] [Related]
32. Refractory septic shock: efficacy and safety of very high doses of norepinephrine.
Katsaragakis S; Kapralou A; Theodorou D; Markogiannakis H; Larentzakis A; Stamou KM; Drimousis P; Bramis I
Methods Find Exp Clin Pharmacol; 2006 Jun; 28(5):307-13. PubMed ID: 16845448
[TBL] [Abstract][Full Text] [Related]
33. The French National Registry of HA-1A (Centoxin) in septic shock. A cohort study of 600 patients. The National Committee for the Evaluation of Centoxin.
Arch Intern Med; 1994 Nov; 154(21):2484-91. PubMed ID: 7979845
[TBL] [Abstract][Full Text] [Related]
34. Terlipressin in the treatment of late phase catecholamine-resistant septic shock.
Svoboda P; Scheer P; Kantorová I; Doubek J; Dudra J; Radvan M; Radvanova J
Hepatogastroenterology; 2012 Jun; 59(116):1043-7. PubMed ID: 22580654
[TBL] [Abstract][Full Text] [Related]
35. Effect of norepinephrine on the outcome of septic shock.
Martin C; Viviand X; Leone M; Thirion X
Crit Care Med; 2000 Aug; 28(8):2758-65. PubMed ID: 10966247
[TBL] [Abstract][Full Text] [Related]
36. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.
Hall LG; Oyen LJ; Taner CB; Cullinane DC; Baird TK; Cha SS; Sawyer MD
Pharmacotherapy; 2004 Aug; 24(8):1002-12. PubMed ID: 15338849
[TBL] [Abstract][Full Text] [Related]
37. Incidence and clinical effects of intra-abdominal hypertension in critically ill patients.
Vidal MG; Ruiz Weisser J; Gonzalez F; Toro MA; Loudet C; Balasini C; Canales H; Reina R; Estenssoro E
Crit Care Med; 2008 Jun; 36(6):1823-31. PubMed ID: 18520642
[TBL] [Abstract][Full Text] [Related]
38. Risk factors for mortality in traumatic cervical spinal cord injury: Brazilian data.
Neumann CR; Brasil AV; Albers F
J Trauma; 2009 Jul; 67(1):67-70. PubMed ID: 19590310
[TBL] [Abstract][Full Text] [Related]
39. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock.
Russell JA; Walley KR; Gordon AC; Cooper DJ; Hébert PC; Singer J; Holmes CL; Mehta S; Granton JT; Storms MM; Cook DJ; Presneill JJ;
Crit Care Med; 2009 Mar; 37(3):811-8. PubMed ID: 19237882
[TBL] [Abstract][Full Text] [Related]
40. Lactate concentrations in the rectal lumen in patients in early septic shock.
Ibsen M; Tenhunen J; Wiis J; Waldau T; Lauritsen AØ; Thornberg K; Joensen H; Perner A
Acta Anaesthesiol Scand; 2010 Aug; 54(7):827-32. PubMed ID: 20560883
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
